Presumably, amplification of the gene ERBB2 is a biological indication of a more aggressive cancer phenotype; it has been shown that HER2 overexpression, due to amplification of this gene, in GC is associated with worse prognosis [21–23]. Here, ERBB2 is linked to cancer.